» Articles » PMID: 38375425

Association Study of Human Leukocyte Antigen Variants and Idiopathic Pulmonary Fibrosis

Abstract

Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial pneumonia marked by progressive lung fibrosis and a poor prognosis. Recent studies have highlighted the potential role of infection in the pathogenesis of IPF, and a prior association of the gene with idiopathic fibrotic interstitial pneumonia (including IPF) has been reported. Owing to the important role that the human leukocyte antigen (HLA) region plays in the immune response, here we evaluated if HLA genetic variation was associated specifically with IPF risk.

Methods: We performed a meta-analysis of associations of the HLA region with IPF risk in individuals of European ancestry from seven independent case-control studies of IPF (comprising 5159 cases and 27 459 controls, including a prior study of fibrotic interstitial pneumonia). Single nucleotide polymorphisms, classical HLA alleles and amino acids were analysed and signals meeting a region-wide association threshold of p<4.5×10 and a posterior probability of replication >90% were considered significant. We sought to replicate the previously reported association in the subset of studies independent of the original report.

Results: The meta-analysis of all seven studies identified four significant independent single nucleotide polymorphisms associated with IPF risk. However, none met the posterior probability for replication criterion. The association was not replicated in the independent IPF studies.

Conclusion: Variation in the HLA region was not consistently associated with risk in studies of IPF. However, this does not preclude the possibility that other genomic regions linked to the immune response may be involved in the aetiology of IPF.

Citing Articles

Elucidating the causal associations and mechanisms between circulating immune cells and idiopathic pulmonary fibrosis: new insights from Mendelian randomization and transcriptomics.

Yang H, Wu X, Xiao X, Chen J, Yu X, Zhao W Front Immunol. 2025; 15:1437984.

PMID: 39896814 PMC: 11782250. DOI: 10.3389/fimmu.2024.1437984.


Tertiary lymphoid structures and B-cell infiltration are IPF features with functional consequences.

Cocconcelli E, Balestro E, Turato G, Fiorentu G, Bazzan E, Biondini D Front Immunol. 2024; 15:1437767.

PMID: 39464888 PMC: 11502372. DOI: 10.3389/fimmu.2024.1437767.


Genomic and Serological Rheumatoid Arthritis Biomarkers, Promoter Variant, and Interstitial Lung Abnormalities.

Kim J, Flack K, Malik V, Manichaikul A, Sakaue S, Luo Y Ann Am Thorac Soc. 2024; .

PMID: 39405163 PMC: 11708761. DOI: 10.1513/AnnalsATS.202403-238OC.


Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine.

Adegunsoye A, Kropski J, Behr J, Blackwell T, Corte T, Cottin V Am J Respir Crit Care Med. 2024; 210(4):401-423.

PMID: 38573068 PMC: 11351799. DOI: 10.1164/rccm.202401-0238SO.

References
1.
Magro C, Allen J, Pope-Harman A, Waldman W, Moh P, Rothrauff S . The role of microvascular injury in the evolution of idiopathic pulmonary fibrosis. Am J Clin Pathol. 2003; 119(4):556-67. DOI: 10.1309/0B06-Y93E-GE6T-Q36Y. View

2.
Mehta P, Rosas I, Singer M . Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity. Intensive Care Med. 2022; 48(12):1803-1806. PMC: 9453725. DOI: 10.1007/s00134-022-06877-w. View

3.
Reynolds C, Sisodia R, Barber C, Moffatt M, Minelli C, De Matteis S . What role for asbestos in idiopathic pulmonary fibrosis? Findings from the IPF job exposures case-control study. Occup Environ Med. 2023; 80(2):97-103. PMC: 9887381. DOI: 10.1136/oemed-2022-108404. View

4.
Donoghue L, Stockwell A, Neighbors M, Sheng R, Prabhakaran R, Wolters P . Identification of a Genetic Susceptibility Locus for Idiopathic Pulmonary Fibrosis in the 16p Subtelomere Using Whole-Genome Sequencing. Am J Respir Crit Care Med. 2023; 207(7):941-944. PMC: 10111979. DOI: 10.1164/rccm.202206-1139LE. View

5.
Tom J, Chang D, Wuster A, Mukhyala K, Cuenco K, Cowgill A . Enabling genome-wide association testing with multiple diseases and no healthy controls. Gene. 2018; 684:118-123. DOI: 10.1016/j.gene.2018.10.047. View